![](/img/cover-not-exists.png)
Efegatran sulphate has no advantage over heparin as an adjunct to thrombolytic therapy in acute myocardial infarction
Briain D. MacNeill, Ik-Kyung JangVolume:
6
Year:
2002
Language:
english
DOI:
10.1054/ebcm.2002.0499
File:
PDF, 88 KB
english, 2002